In addition to showing higher affinity for the asialoglycoprotein receptor (ASGPR) when compared with free DOX, ASP exerted more significant inhibition of tumor cell proliferation, while reducing the side effects of free DOX (Zhang Y. et al., 2019). This evidence concerns the gene ASGR1 and neoplasm.